RxDoctor Payments Data

Kathryn Fritz

Adult Health · Canton, OHNPI 1275635153

Payments from drug & device makers

$1,624in general payments, 2019–2025

Across 89 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$439
  • Lilly USA, LLC$251
  • Bayer$88
  • Amgen$62
  • Novartis$61
  • Corcept Therapeutics$57
  • plus $667 from 20 others

What the payments were for

  • Food & beverage$1,60099%
  • Education$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,624 in reported general payments places this provider in the 75th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide109$138,188
JardianceEmpagliflozin118$115,170
Tresiba Flextouch U-200Insulin Degludec72$83,305
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog42$49,311
FarxigaDapagliflozin Propanediol59$43,168
TrulicityDulaglutide27$39,786
Synjardy XrEmpagliflozin/Metformin Hcl23$27,161
Humulin R U-500 KwikpenInsulin Regular, Human14$23,287
MounjaroTirzepatide16$21,633
Humalog Kwikpen U-100Insulin Lispro71$18,639
Tresiba Flextouch U-100Insulin Degludec35$18,222
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/712$16,241
Janumet XrSitagliptin Phos/Metformin Hcl17$15,329
Novolog FlexpenInsulin Aspart39$15,103
Fiasp FlextouchInsulin Aspart (Niacinamide)16$13,746

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$48$154,764158 claims
Novo NordiskOzempic, Novolog$439$140,105123 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$251$64,13155 claims
AstraZenecaFarxiga$52$43,16859 claims
IBSA Pharma Inc.Tirosint$16$1,81214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,184 adult health providers in Ohio.

Other adult health in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →